Get started
Author

Anna Pereira Fernandes

Observed name: A. Pereira-Fernandes
Institution: Galapagos (Belgium)
Observed institution: Galapagos (Belgium)
OpenAlex ID: A5113080912
Discovery of Clinical Candidate GLPG3970: A Potent and Selective Dual SIK2/SIK3 Inhibitor for the Treatment of Autoimmune and Inflammatory Diseases
2024 · Christophe Peixoto, Agnes Joncour, et al. · Journal of Medicinal Chemistry · 27
Optimization of Selectivity and Pharmacokinetic Properties of Salt-Inducible Kinase Inhibitors that Led to the Discovery of Pan-SIK Inhibitor GLPG3312
2023 · Taouès Temal-Laib, Christophe Peixoto, et al. · Journal of Medicinal Chemistry · 22
PDF
Pos0442 Glpg4399: Selective Sik3 Inhibition as a Novel Mode of Action for the Treatment of Inflammatory Arthritic Diseases (preclinical)
2022 · S. Lavazais, A. Pereira-Fernandes, et al. · Annals of the Rheumatic Diseases · 4
PDF
Selective SIK2/SIK3 inhibition reprograms pro- and antiinflammatory pathways in myeloid cells, improving autoimmune disease outcomes
2026 · Steve De Vos, Nicolas Desroy, et al. · JCI Insight · 3
PDF
Discovery of GLPG4471, a potent and selective IRAK4 inhibitor for the treatment of inflammatory and autoimmune diseases
2025 · Oscar Mammoliti, Florence Bonnaterre, et al. · Bioorganic & Medicinal Chemistry Letters
Works count: 5
Citation count: 56
H-index: 3
I10-index: 2
Year
Topic
Type